查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954694

藥品檢測設備市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2026-2034年）

Pharmaceutical Inspection Machines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

藥品檢測設備市場成長驅動因素

2025年全球藥品檢測設備市場規模為 10.221億美元，預計將從2026年的11.032億美元成長至2034年的22.635億美元，預測期內年複合成長率（CAGR）為 9.40%。亞太地區將在2025年佔據全球市場 37.20%的佔有率，這反映了新興經濟體藥品製造業的顯著擴張。

藥品檢測設備是一種自動化和半自動化系統，用於藥品生產，以確保產品品質、包裝完整性和符合法規要求。這些系統能夠偵測外觀、尺寸和包裝方面的缺陷，驗證標籤和程式碼，並識別肉眼不可見的缺陷。這些系統的應用能夠提高生產效率，降低召回風險，確保病患安全，並支持序列化和防偽措施。

市場動態

市場驅動因素

日益嚴格的監管和品質合規要求是市場成長的主要驅動力。遵守FDA等監管機構和良好生產規範（GMP）的要求，需要對無菌生產、序列化和可追溯性進行嚴格的驗證流程。先進的檢測技術顯著減少了因品質問題導致的藥品召回。新興地區藥品生產外包的增加，進一步強化了各生產基地標準化檢測系統的需求。

對病患安全和高品質藥品的日益重視，迫使製造商將其傳統的檢測系統升級為自動化和人工智慧解決方案。

市場挑戰

儘管成長潛力巨大，但巨額資本支出（CAPEX）仍然是一項重大挑戰。採購除了需要獲得監管部門的批准外，還需要經過漫長的實施確認（IQ）、運行確認（OQ）和效能確認（PQ）驗證週期。這些延長的驗證週期會導致採購決策延遲和設備升級週期延長，尤其對於中小型製造商而言更是如此。

市場機會

人工智慧驅動的檢測系統和軟體即服務（SaaS）平台的採用帶來了巨大的成長機會。基於人工智慧的深度學習模型可以減少誤報，提高偵測精度，並實現預測分析。訂閱式監控和模型更新為供應商提供了持續的收入來源。

2021年 2月，Syntegon Technology 部署了首個經過全面驗證的人工智慧驅動視覺檢測系統，標誌著智慧製造領域的突破性進展。此外，工業4.0的整合，包括配備感測器的機械設備和互聯生產線，加速藥品企業的數位轉型。

市場趨勢

感測器融合和組合檢測系統的整合是一個顯著的趨勢。製造商採用整合視覺系統、X射線檢測、金屬檢測、楔入式檢測和洩漏檢測的平台，以減少生產線的佔地面積並提高缺陷檢測的準確性。

此外，個人化醫療和生物藥品生產的興起加速專門用於無菌注射劑和生物製品的檢測工具的開發。

細分市場分析

依組件劃分

到2026年，硬體細分市場將佔82.19%的市場佔有率，並創造7.841億美元的收入。對自動化視覺檢測（AVI）、X射線系統、洩漏檢測系統和組合檢測設備的強勁需求推動硬體市場的成長。

軟體領域預計將以9.6%的年複合成長率（CAGR）實現最高成長，這主要得益於人工智慧分析、序列化系統以及追蹤溯源技術的日益普及。

依包裝類型劃分

注射劑領域將在2026年佔據最大的市場佔有率，達到43.25%，同時也將以9.6%的年複合成長率成為成長最快的領域。生物藥品和疫苗研發管線的擴張推動對先進系統的需求成長，這些系統需要嚴格的容器密封完整性測試（CCIT）和顆粒檢測。

依劑型劃分

口服藥物領域在2024年創造了3.969億美元的市場規模，主要得益於片劑和膠囊的高消費量。然而，隨著無菌注射劑產量的不斷成長，預計到2026年，注射劑市場將佔據主導地位，市場佔有率達到41.52%。生物藥品和疫苗預計將以10.6%的年複合成長率（CAGR）成長，直至2034年。

依類型

全自動系統在2024年創造6.649億美元的銷售額，並將繼續佔據主導地位，這得益於其高效性和減少人為錯誤。在機器人技術和人工智慧工作流程整合的推動下，該細分市場正以9.2%的年複合成長率（CAGR）快速成長。

依最終使用者

藥品公司將在2024年以5.29億美元的銷售額引領市場，這主要得益於現有生產線的現代化改造。生技公司預計將以10.0%的年複合成長率（CAGR）成長，這主要得益於其生物製品生產能力的擴張。

區域展望

亞太地區

亞太地區市場規模在2025年達到3.797億美元，並在2026年達到4.166億美元。預計到2034年，該地區將維持10.6%的最高年複合成長率。中國和印度是主要貢獻者，預計到2026年，兩國市場規模將分別達到2.045億美元和6,190萬美元。

北美

在強勁的研發投入和嚴格的監管合規的支撐下，北美地區在2025年和2026年分別紀錄2.766億美元和2.98億美元的市場規模。光是美國預計在2026年就將達到2.569億美元。

歐洲

在監管執法和檢測技術創新的支持下，到2025年，歐洲創造2.25億美元的收入。德國、英國和義大利仍將是主要貢獻者。

南美洲及中東及非洲

到2025年，南美洲和中東及非洲地區的市場規模分別達到8,070萬美元和6,010萬美元。這主要歸功於藥品產量的增加和監管的改善。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 宏觀與微觀經濟指標
  • 驅動因素、限制因素、機會與趨勢

第4章 競爭格局

  • 主要公司採用的商業策略
  • 整合主要公司 SWOT 分析
  • 全球前3-5 大藥品檢測設備公司市場佔有率/排名（2025年）

第5章 全球藥品檢測設備市場規模估算與預測：依細分市場劃分（2021-2034年）

  • 主要發現
  • 依組件劃分
    • 硬體
      • AVI 系統
      • X 射線偵測系統
      • 洩漏檢測系統
      • 金屬探測器
      • 檢漏儀
      • 組合系統
      • 其他
    • 軟體
  • 依包裝類型劃分
    • 注射劑
    • 瓶裝
    • 泡罩包裝
    • 其他
  • 依劑型
    • 口服
    • 注射劑
    • 生物製品/疫苗
    • 其他
  • 依類型
    • 全自動
    • 半自動
    • 手動
  • 依最終用戶
    • 藥品公司
    • 生技公司
    • 委託生產組織（CMO）與委託開發暨製造組織（CDMO）
    • 其他
  • 依地區
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東和非洲

第6章 北美藥品檢測設備市場規模估算與預測：依細分市場劃分（2021-2034）

  • 依國家/地區
    • 美國
    • 加拿大
    • 墨西哥

第7章 南美洲藥品檢測設備市場規模估算與預測：依細分市場劃分（2021-2034年）

  • 依國家劃分
    • 巴西
    • 阿根廷
    • 其他南美國家

第8章 歐洲藥品檢測設備市場規模估算與預測：依細分市場劃分（2021-2034年）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 其他歐洲國家

第9章 藥品檢測設備市場估算與預測亞太地區市場規模：依細分市場劃分（2021-2034年）

  • 依國家劃分
    • 中國
    • 日本
    • 韓國
    • 印度
    • 其他亞太地區

第10章 中東與非洲藥品檢測設備市場規模估計與預測：依細分市場劃分（2021-2034年）

  • 依國家劃分
    • GCC
    • 南非
    • 其他中東和非洲地區

第11章 前十大公司簡介

  • ACG Group
  • Antares Vision Group
  • Cognex Corporation
  • Keyence Corporation
  • Mettler-Toledo
  • Minebea Intec
  • OPTEL Group
  • Stevanato Group
  • Syntegon Technology
  • Uhlmann Pac-Systeme

第12章 要點

Product Code: FBI114077

Growth Factors of pharmaceutical inspection machines Market

The global pharmaceutical inspection machines market size was valued at USD 1,022.10 million in 2025 and is projected to grow from USD 1,103.20 million in 2026 to USD 2,263.50 million by 2034, exhibiting a CAGR of 9.40% during the forecast period. Asia Pacific dominated the global market with a 37.20% share in 2025, reflecting strong pharmaceutical manufacturing expansion across emerging economies.

Pharmaceutical inspection machines are automated and semi-automated systems used in drug manufacturing to ensure product quality, packaging integrity, and regulatory compliance. These systems detect visual, dimensional, and packaging defects, verify labels and codes, and identify non-visible faults. Their adoption enhances throughput, reduces recall risks, ensures patient safety, and supports serialization and anti-counterfeit measures.

Market Dynamics

Market Drivers

Rising regulatory and quality compliance requirements are major drivers of market growth. Regulatory authorities such as the FDA and adherence to Good Manufacturing Practices (GMP) require strict validation processes for sterile manufacturing, serialization, and traceability. Advanced inspection technologies have significantly reduced drug recalls due to quality issues. Increasing pharmaceutical outsourcing in emerging regions has further strengthened the demand for standardized inspection systems across manufacturing sites.

Growing emphasis on patient safety and high-quality pharmaceutical products is compelling manufacturers to upgrade legacy inspection systems with automated and AI-enabled solutions.

Market Challenges

Despite strong growth potential, high capital expenditure (CAPEX) requirements pose a key challenge. Procurement involves lengthy Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) validation cycles, along with regulatory approvals. These extended validation timelines delay purchasing decisions and slow equipment refresh cycles, particularly for small and mid-sized manufacturers.

Market Opportunities

The adoption of AI-driven inspection systems and Software-as-a-Service (SaaS) platforms presents significant growth opportunities. AI-based deep-learning models reduce false rejects, improve detection accuracy, and enable predictive analytics. Subscription-based monitoring and model updates create recurring revenue streams for vendors.

In February 2021, Syntegon Technology installed one of the first fully validated AI-driven visual inspection systems, marking a milestone in smart manufacturing. Furthermore, Industry 4.0 integration, including sensor-enabled machines and connected production lines, is accelerating digital transformation in pharmaceutical facilities.

Market Trends

Integration of sensor fusion and combination inspection systems is a prominent trend. Manufacturers are deploying unified platforms combining vision systems, X-ray inspection, metal detection, checkweighing, and leak detection to reduce production line footprints and enhance defect detection accuracy.

Additionally, the rise of personalized medicine and biopharmaceutical production is encouraging the development of specialized inspection tools tailored for sterile injectables and biologics.

Segmentation Analysis

By Component

The hardware segment dominated with an 82.19% market share in 2026, generating USD 784.1 million in revenue. Strong demand for automated visual inspection (AVI), X-ray systems, leak detection systems, and combination machines drives hardware growth.

The software segment is projected to grow at the highest CAGR of 9.6%, supported by increasing adoption of AI-based analytics, serialization systems, and track-and-trace technologies.

By Packaging Type

The injectables segment held the largest share of 43.25% in 2026 and is also the fastest-growing segment with a CAGR of 9.6%. Growing biologics and vaccine pipelines require stringent container closure integrity testing (CCIT) and particle inspection, boosting demand for advanced systems.

By Formulation

The oral segment generated USD 396.9 million in 2024, driven by high consumption of tablets and capsules. However, the parenteral segment is projected to dominate with a 41.52% share in 2026 due to rising sterile injectable production. Biologics and vaccines are expected to grow at the highest CAGR of 10.6% through 2034.

By Type

Fully automated systems generated USD 664.9 million in 2024 and remain dominant due to efficiency and reduced manual errors. This segment is also the fastest-growing, with a CAGR of 9.2%, supported by robotics integration and AI-enabled workflows.

By End User

Pharmaceutical companies led the market with USD 529.0 million in 2024, driven by modernization of legacy production lines. Biotechnology companies are expected to grow at the highest CAGR of 10.0%, fueled by expanding biologics manufacturing capacity.

Regional Outlook

Asia Pacific

Asia Pacific generated USD 379.7 million in 2025 and is projected to reach USD 416.6 million in 2026, maintaining the highest CAGR of 10.6% through 2034. China and India are key contributors, expected to generate USD 204.5 million and USD 61.9 million respectively in 2026.

North America

North America recorded USD 276.6 million in 2025 and USD 298.0 million in 2026, driven by strong R&D investments and strict regulatory compliance. The U.S. alone accounted for USD 256.9 million in 2026.

Europe

Europe generated USD 225.0 million in 2025, supported by regulatory enforcement and innovation in inspection technologies. Germany, the U.K., and Italy remain key contributors.

South America and Middle East & Africa

South America and the Middle East & Africa reached USD 80.7 million and USD 60.1 million respectively in 2025, driven by pharmaceutical production expansion and regulatory improvements.

Competitive Landscape

The market is highly fragmented, with key players including ACG Group, Antares Vision Group, Cognex Corporation, Stevanato Group, Syntegon Technology, Uhlmann Pac-Systeme, Loma Systems, Mettler-Toledo, Minebea Intec, and OPTEL Group. Strategic partnerships, AI innovation, mergers, and product launches strengthen competitive positioning.

Conclusion

The pharmaceutical inspection machines market is set for strong growth, expanding from USD 1,022.10 million in 2025 to USD 2,263.50 million by 2034, at a CAGR of 9.40%. Rising regulatory compliance requirements, growth in biologics and injectables, and increasing adoption of AI-driven inspection systems are driving market expansion. Although high capital costs and lengthy validation cycles remain challenges, digital transformation and smart manufacturing initiatives are expected to sustain long-term market growth globally.

Segmentation By Component

  • Hardware
    • AVI Systems
    • X-Ray Inspection Systems
    • Leak Detection Systems
    • Metal Detectors
    • Checkweighers
    • Combination Systems
    • Others
  • Software

By Packaging Type

  • Injectables
  • Bottles
  • Blisters
  • Others

By Formulation

  • Oral
  • Parenteral
  • Biologics/Vaccines
  • Others

By Type

  • Fully Automated
  • Semi Automated
  • Manual

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • CMOs & CDMOs
  • Others

By Region

  • North America (By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • U.S. (By Type)
    • Canada (By Type)
    • Mexico (By Type)
  • Europe ( Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • U.K. (By Type)
    • Germany (By Type )
    • France (By Type )
    • Italy (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • China (By Type)
    • Japan (By Type)
    • India (By Type)
    • Rest of Asia Pacific (By Type)
  • South America (By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • Argentina (By Type)
    • Brazil (By Type)
    • Rest of South America (By Type)
  • Middle East & Africa (By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • GCC (By Type )
    • South Africa (By Type )
  • Rest of the Middle East & Africa (By Type )

Table of Content

1. Introduction

  • 1.1. Definition, By Segment
  • 1.2. Research Methodology/Approach
  • 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

  • 3.1. Macro and Micro Economic Indicators
  • 3.2. Drivers, Restraints, Opportunities and Trends

4. Competition Landscape

  • 4.1. Business Strategies Adopted by Key Players
  • 4.2. Consolidated SWOT Analysis of Key Players
  • 4.3. Global Pharmaceutical Inspection Machines Key Players (Top 3 - 5) Market Share/Ranking, 2025

5. Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 5.1. Key Findings
  • 5.2. By Component (USD)
    • 5.2.1. Hardware
      • 5.2.1.1. AVI Systems
      • 5.2.1.2. X-Ray Inspection Systems
      • 5.2.1.3. Leak Detection Systems
      • 5.2.1.4. Metal Detectors
      • 5.2.1.5. Checkweighers
      • 5.2.1.6. Combination Systems
      • 5.2.1.7. Others
    • 5.2.2. Software
  • 5.3. By Packaging Type (USD)
    • 5.3.1. Injectables
    • 5.3.2. Bottles
    • 5.3.3. Blisters
    • 5.3.4. Others
  • 5.4. By Formulation (USD)
    • 5.4.1. Oral
    • 5.4.2. Parenteral
    • 5.4.3. Biologics/Vaccines
    • 5.4.4. Others
  • 5.5. By Type (USD)
    • 5.5.1. Fully Automated
    • 5.5.2. Semi Automated
    • 5.5.3. Manual
  • 5.6. By End User (USD)
    • 5.6.1. Pharmaceutical Companies
    • 5.6.2. Biotechnology Companies
    • 5.6.3. CMOs & CDMOs
    • 5.6.4. Others
  • 5.7. By Region (USD)
    • 5.7.1. North America
    • 5.7.2. South America
    • 5.7.3. Europe
    • 5.7.4. Asia Pacific
    • 5.7.5. Middle East & Africa

6. North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 6.1. Key Findings
  • 6.2. By Component (USD)
    • 6.2.1. Hardware
      • 6.2.1.1. AVI Systems
      • 6.2.1.2. X-Ray Inspection Systems
      • 6.2.1.3. Leak Detection Systems
      • 6.2.1.4. Metal Detectors
      • 6.2.1.5. Checkweighers
      • 6.2.1.6. Combination Systems
      • 6.2.1.7. Others
    • 6.2.2. Software
  • 6.3. By Packaging Type (USD)
    • 6.3.1. Injectables
    • 6.3.2. Bottles
    • 6.3.3. Blisters
    • 6.3.4. Others
  • 6.4. By Formulation (USD)
    • 6.4.1. Oral
    • 6.4.2. Parenteral
    • 6.4.3. Biologics/Vaccines
    • 6.4.4. Others
  • 6.5. By Type (USD)
    • 6.5.1. Fully Automated
    • 6.5.2. Semi Automated
    • 6.5.3. Manual
  • 6.6. By End User (USD)
    • 6.6.1. Pharmaceutical Companies
    • 6.6.2. Biotechnology Companies
    • 6.6.3. CMOs & CDMOs
    • 6.6.4. Others
  • 6.7. By Country (USD)
    • 6.7.1. U.S.
      • 6.7.1.1. By Type (USD)
    • 6.7.2. Canada
      • 6.7.2.1. By Type (USD)
    • 6.7.3. Mexico
      • 6.7.3.1. By Type (USD)

7. South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 7.1. Key Findings
  • 7.2. By Component (USD)
    • 7.2.1. Hardware
      • 7.2.1.1. AVI Systems
      • 7.2.1.2. X-Ray Inspection Systems
      • 7.2.1.3. Leak Detection Systems
      • 7.2.1.4. Metal Detectors
      • 7.2.1.5. Checkweighers
      • 7.2.1.6. Combination Systems
      • 7.2.1.7. Others
    • 7.2.2. Software
  • 7.3. By Packaging Type (USD)
    • 7.3.1. Injectables
    • 7.3.2. Bottles
    • 7.3.3. Blisters
    • 7.3.4. Others
  • 7.4. By Formulation (USD)
    • 7.4.1. Oral
    • 7.4.2. Parenteral
    • 7.4.3. Biologics/Vaccines
    • 7.4.4. Others
  • 7.5. By Type (USD)
    • 7.5.1. Fully Automated
    • 7.5.2. Semi Automated
    • 7.5.3. Manual
  • 7.6. By End User (USD)
    • 7.6.1. Pharmaceutical Companies
    • 7.6.2. Biotechnology Companies
    • 7.6.3. CMOs & CDMOs
    • 7.6.4. Others
  • 7.7. By Country (USD)
    • 7.7.1. Brazil
      • 7.7.1.1. By Type (USD)
    • 7.7.2. Argentina
      • 7.7.2.1. By Type (USD)
    • 7.7.3. Rest of South America

8. Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 8.1. Key Findings
  • 8.2. By Component (USD)
    • 8.2.1. Hardware
      • 8.2.1.1. AVI Systems
      • 8.2.1.2. X-Ray Inspection Systems
      • 8.2.1.3. Leak Detection Systems
      • 8.2.1.4. Metal Detectors
      • 8.2.1.5. Checkweighers
      • 8.2.1.6. Combination Systems
      • 8.2.1.7. Others
    • 8.2.2. Software
  • 8.3. By Packaging Type (USD)
    • 8.3.1. Injectables
    • 8.3.2. Bottles
    • 8.3.3. Blisters
    • 8.3.4. Others
  • 8.4. By Formulation (USD)
    • 8.4.1. Oral
    • 8.4.2. Parenteral
    • 8.4.3. Biologics/Vaccines
    • 8.4.4. Others
  • 8.5. By Type (USD)
    • 8.5.1. Fully Automated
    • 8.5.2. Semi Automated
    • 8.5.3. Manual
  • 8.6. By End User (USD)
    • 8.6.1. Pharmaceutical Companies
    • 8.6.2. Biotechnology Companies
    • 8.6.3. CMOs & CDMOs
    • 8.6.4. Others
  • 8.7. By Country (USD)
    • 8.7.1. Germany
      • 8.7.1.1. By Type (USD)
    • 8.7.2. U.K.
      • 8.7.2.1. By Type (USD)
    • 8.7.3. France
      • 8.7.3.1. By Type (USD)
    • 8.7.4. Italy
      • 8.7.4.1. By Type (USD)
    • 8.7.5. Rest of Europe

9. Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 9.1. Key Findings
  • 9.2. By Component (USD)
    • 9.2.1. Hardware
      • 9.2.1.1. AVI Systems
      • 9.2.1.2. X-Ray Inspection Systems
      • 9.2.1.3. Leak Detection Systems
      • 9.2.1.4. Metal Detectors
      • 9.2.1.5. Checkweighers
      • 9.2.1.6. Combination Systems
      • 9.2.1.7. Others
    • 9.2.2. Software
  • 9.3. By Packaging Type (USD)
    • 9.3.1. Injectables
    • 9.3.2. Bottles
    • 9.3.3. Blisters
    • 9.3.4. Others
  • 9.4. By Formulation (USD)
    • 9.4.1. Oral
    • 9.4.2. Parenteral
    • 9.4.3. Biologics/Vaccines
    • 9.4.4. Others
  • 9.5. By Type (USD)
    • 9.5.1. Fully Automated
    • 9.5.2. Semi Automated
    • 9.5.3. Manual
  • 9.6. By End User (USD)
    • 9.6.1. Pharmaceutical Companies
    • 9.6.2. Biotechnology Companies
    • 9.6.3. CMOs & CDMOs
    • 9.6.4. Others
  • 9.7. By Country (USD)
    • 9.7.1. China
      • 9.7.1.1. By Type (USD)
    • 9.7.2. Japan
      • 9.7.2.1. By Type (USD)
    • 9.7.3. South Korea
      • 9.7.3.1. By Type (USD)
    • 9.7.4. India
      • 9.7.4.1. By Type (USD)
    • 9.7.5. Rest of Asia Pacific

10. Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 10.1. Key Findings
  • 10.2. By Component (USD)
    • 10.2.1. Hardware
      • 10.2.1.1. AVI Systems
      • 10.2.1.2. X-Ray Inspection Systems
      • 10.2.1.3. Leak Detection Systems
      • 10.2.1.4. Metal Detectors
      • 10.2.1.5. Checkweighers
      • 10.2.1.6. Combination Systems
      • 10.2.1.7. Others
    • 10.2.2. Software
  • 10.3. By Packaging Type (USD)
    • 10.3.1. Injectables
    • 10.3.2. Bottles
    • 10.3.3. Blisters
    • 10.3.4. Others
  • 10.4. By Formulation (USD)
    • 10.4.1. Oral
    • 10.4.2. Parenteral
    • 10.4.3. Biologics/Vaccines
    • 10.4.4. Others
  • 10.5. By Type (USD)
    • 10.5.1. Fully Automated
    • 10.5.2. Semi Automated
    • 10.5.3. Manual
  • 10.6. By End User (USD)
    • 10.6.1. Pharmaceutical Companies
    • 10.6.2. Biotechnology Companies
    • 10.6.3. CMOs & CDMOs
    • 10.6.4. Others
  • 10.7. By Country (USD)
    • 10.7.1. GCC
      • 10.7.1.1. By Type (USD)
    • 10.7.2. South Africa
      • 10.7.2.1. By Type (USD)
    • 10.7.3. Rest of MEA

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

  • 11.1. ACG Group
    • 11.1.1. Overview
      • 11.1.1.1. Key Management
      • 11.1.1.2. Headquarters
      • 11.1.1.3. Offerings/Business Segments
    • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.1.2.1. Employee Size
      • 11.1.2.2. Past and Current Revenue
      • 11.1.2.3. Geographical Share
      • 11.1.2.4. Business Segment Share
      • 11.1.2.5. Recent Developments
  • 11.2. Antares Vision Group
    • 11.2.1. Overview
      • 11.2.1.1. Key Management
      • 11.2.1.2. Headquarters
      • 11.2.1.3. Offerings/Business Segments
    • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.2.2.1. Employee Size
      • 11.2.2.2. Past and Current Revenue
      • 11.2.2.3. Geographical Share
      • 11.2.2.4. Business Segment Share
      • 11.2.2.5. Recent Developments
  • 11.3. Cognex Corporation
    • 11.3.1. Overview
      • 11.3.1.1. Key Management
      • 11.3.1.2. Headquarters
      • 11.3.1.3. Offerings/Business Segments
    • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.3.2.1. Employee Size
      • 11.3.2.2. Past and Current Revenue
      • 11.3.2.3. Geographical Share
      • 11.3.2.4. Business Segment Share
      • 11.3.2.5. Recent Developments
  • 11.4. Keyence Corporation
    • 11.4.1. Overview
      • 11.4.1.1. Key Management
      • 11.4.1.2. Headquarters
      • 11.4.1.3. Offerings/Business Segments
    • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.4.2.1. Employee Size
      • 11.4.2.2. Past and Current Revenue
      • 11.4.2.3. Geographical Share
      • 11.4.2.4. Business Segment Share
      • 11.4.2.5. Recent Developments
  • 11.5. Mettler-Toledo
    • 11.5.1. Overview
      • 11.5.1.1. Key Management
      • 11.5.1.2. Headquarters
      • 11.5.1.3. Offerings/Business Segments
    • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.5.2.1. Employee Size
      • 11.5.2.2. Past and Current Revenue
      • 11.5.2.3. Geographical Share
      • 11.5.2.4. Business Segment Share
      • 11.5.2.5. Recent Developments
  • 11.6. Minebea Intec
    • 11.6.1. Overview
      • 11.6.1.1. Key Management
      • 11.6.1.2. Headquarters
      • 11.6.1.3. Offerings/Business Segments
    • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.6.2.1. Employee Size
      • 11.6.2.2. Past and Current Revenue
      • 11.6.2.3. Geographical Share
      • 11.6.2.4. Business Segment Share
      • 11.6.2.5. Recent Developments
  • 11.7. OPTEL Group
    • 11.7.1. Overview
      • 11.7.1.1. Key Management
      • 11.7.1.2. Headquarters
      • 11.7.1.3. Offerings/Business Segments
    • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.7.2.1. Employee Size
      • 11.7.2.2. Past and Current Revenue
      • 11.7.2.3. Geographical Share
      • 11.7.2.4. Business Segment Share
      • 11.7.2.5. Recent Developments
  • 11.8. Stevanato Group
    • 11.8.1. Overview
      • 11.8.1.1. Key Management
      • 11.8.1.2. Headquarters
      • 11.8.1.3. Offerings/Business Segments
    • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.8.2.1. Employee Size
      • 11.8.2.2. Past and Current Revenue
      • 11.8.2.3. Geographical Share
      • 11.8.2.4. Business Segment Share
      • 11.8.2.5. Recent Developments
  • 11.9. Syntegon Technology
    • 11.9.1. Overview
      • 11.9.1.1. Key Management
      • 11.9.1.2. Headquarters
      • 11.9.1.3. Offerings/Business Segments
    • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.9.2.1. Employee Size
      • 11.9.2.2. Past and Current Revenue
      • 11.9.2.3. Geographical Share
      • 11.9.2.4. Business Segment Share
      • 11.9.2.5. Recent Developments
  • 11.10. Uhlmann Pac-Systeme
    • 11.10.1. Overview
      • 11.10.1.1. Key Management
      • 11.10.1.2. Headquarters
      • 11.10.1.3. Offerings/Business Segments
    • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.10.2.1. Employee Size
      • 11.10.2.2. Past and Current Revenue
      • 11.10.2.3. Geographical Share
      • 11.10.2.4. Business Segment Share
      • 11.10.2.5. Recent Developments

12. Key Takeaways

List of Tables

  • Table 1: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 2: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 3: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 4: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 5: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 6: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 7: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Region, 2021 - 2034
  • Table 8: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 9: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 10: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 11: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 12: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 13: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 14: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 15: U.S. Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 16: Canada Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 17: Mexico Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 18: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 19: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 20: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 21: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 22: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 23: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 24: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 25: Germany Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 26: France Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 27: Italy Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 28: United Kingdom Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 29: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 30: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 31: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 32: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 33: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 34: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 35: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 36: China Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 37: Japan Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 38: India Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 39: South Korea Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 40: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 41: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 42: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 43: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 44: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 45: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 46: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 47: GCC Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 48: South Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 49: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 50: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 51: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 52: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 53: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 54: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 55: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 56: Brazil Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 57: Argentina Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034

List of Figures

  • Figure 1: Global Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 2: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 3: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 4: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 5: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 6: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 7: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Region, 2025 and 2034
  • Figure 8: North America Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 9: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 10: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 11: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 12: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 13: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 14: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 15: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 16: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 17: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 18: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 19: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 20: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 21: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 22: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 23: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 24: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 25: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 26: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 27: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 28: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 29: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 30: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 31: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 32: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 33: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 34: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 35: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 36: South America Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 37: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 38: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 39: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 40: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 41: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 42: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 43: Global Pharmaceutical Inspection Machines Key Players' Market Share/Ranking (%), 2025